article thumbnail

Heart failure market to grow at 9.6 per cent CAGR in 7MM during 2022-32

Express Pharma

billion in 2022 to $33.7 Kajal Jaddoo, Senior Pharma Analyst at GlobalData, comments, The pressure for pharmaceutical companies to be more innovative with their therapies and tackle unmet needs is increasing. per cent CAGR in 7MM during 2022-32 appeared first on Express Pharma.

article thumbnail

Understanding the Regulatory Environment in Japan for Generic Drug Development

Drug Patent Watch

This article aims to provide a comprehensive overview of the key aspects of the regulatory framework, highlighting the requirements and challenges faced by pharmaceutical companies seeking to introduce generic drugs into the Japanese market. References Tanaka, M., Clinical Pharmacology & Therapeutics , 111(3), 531538.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Benefits of Integrated CDMO Services: Streamlining Drug Development and Manufacturing

Drug Patent Watch

The Rise of Integrated CDMOs The global biotechnology and pharmaceutical services outsourcing market size was valued at $70.48 billion in 2022 and is expected to grow at a compound annual growth rate of 5.3% from 2023 to 2030.

article thumbnail

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

article thumbnail

Asahi Kasei establishes life science division to streamline bioprocess operations for pharma sector

Express Pharma

based Bionique Testing Laboratories (2021), and biologics CDMO Bionova Scientific (2022). We will contribute to the advancement of the pharmaceutical industry as a premium partner that provides innovative and reliable products and services to pharmaceutical companies.

article thumbnail

Addressing US FDA challenges in Indian sterile drug manufacturing – Part 1

Express Pharma

Indian pharmaceutical companies supply more than 60 per cent of global demand for vaccines and over 40 per cent of generic medicines consumed in the United States (2). For instance, India’s role as a major supplier of COVID-19 vaccines underscored its capabilities in high-volume sterile manufacturing (4). and EU markets.

article thumbnail

AZ boasts phase 3 win for self-administered gMG drug

pharmaphorum

Skip to main content Thursday 24 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)